The HCV-Dependent Inhibition of Nrf1/ARE-Mediated Gene Expression Favours Viral Morphogenesis

Area of Science:

• Virology
• Molecular Biology
• Hepatology

Background:

• Hepatitis C virus (HCV) infection is linked to lipid metabolism disruptions.
• Nuclear factor erythroid 2 related factor-1 (Nrf1) is a cholesterol sensor crucial for liver protection.
• Nrf1 responds to oxidative stress by binding small Maf proteins (sMaf) to the antioxidant response element (ARE).

Purpose of the Study:

• To investigate the interaction between Nrf1 and HCV replication.
• To understand how HCV affects Nrf1 function and downstream pathways.
• To explore the role of Nrf1 in HCV pathogenesis.

Main Methods:

• Analysis of Nrf1 levels and activity in HCV-replicating cells.
• Assessment of sMaf protein localization and availability.
• Evaluation of cholesterol metabolism markers and LXRα promoter activity.
• Kinome profiling to identify molecular changes associated with Nrf1 inhibition.

Main Results:

• HCV replication leads to reduced Nrf1 levels and impaired activation of Nrf1-dependent genes.
• Small Maf proteins (sMaf) are sequestered in viral replicase complexes, limiting nuclear Nrf1 function.
• Impaired Nrf1 activity results in elevated intracellular cholesterol and inhibited LXRα activation.
• Nrf1 inhibition correlates with steatosis and inflammation, contributing to HCV pathogenesis.
• Reduced Nrf1 function favors viral morphogenesis, increasing HCV replication and progeny production.

Conclusions:

• HCV disrupts Nrf1-dependent gene activation by sequestering sMaf proteins.
• Impaired Nrf1 activity contributes to altered lipid metabolism and promotes HCV replication.
• Targeting Nrf1 may offer a therapeutic strategy against HCV.